Personalized dose selection platform for patients with solid tumors in the PRECISE CURATE.AI feasibility trial. - Blasiak A; Truong ATL; Foo N; Tan LWJ; Kumar KS; Tan SB; Teo CB; Tan BKJ; Tadeo X; Tan HL; Chee CE; Yong WP; et al. (NPJ precision oncology, 2025)